Rosacea

Rosacea, a common chronic disorder of the skin, is usually a clinical diagnosis; avoidance of triggers is key to management.

The most common manifestations are flushing, dilated prominent telangiectases (primarily on the face), persistent facial erythema, inflammatory papules, and pustules on the peri-orificial face.

Prominence of sebaceous glands on the nose may result in fibrosis and rhinophyma.

Typically, mild disease is initially treated with topical metronidazole or oral tetracyclines. Other antibiotics and anti-inflammatory agents can be used as adjuncts.

Rosacea is a common chronic disorder of the skin characterised by redness, flushing, and other cutaneous findings that often include telangiectases, roughened skin, rhinophyma, and general inflammation that can resemble acne. It primarily affects the convexities of the central face, including the cheeks, chin, nose, and central forehead, but it may extend to other parts of the body (usually the upper trunk).[1]Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018 Jan;78(1):148-55. http://www.ncbi.nlm.nih.gov/pubmed/29089180?tool=bestpractice.com People with rosacea can also experience watery or irritated eyes. Rosacea is typified by episodes of remission and recurrence.